PHARMACYCLICS INC Excess Tax Benefit from Share-based Compensation, Operating Activities
PHARMACYCLICS INC reported Excess Tax Benefit from Share-based Compensation, Operating Activities of $18.02 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-04.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities · last filed 2015-05-04
- PHARMACYCLICS INC excess tax benefit from share-based compensation, operating activities for the quarter ending 2015-03-31 was $18.02M.
- PHARMACYCLICS INC excess tax benefit from share-based compensation, operating activities for the quarter ending 2014-12-31 was $27.30M, a 39.81% increase year-over-year.
- PHARMACYCLICS INC excess tax benefit from share-based compensation, operating activities for the quarter ending 2014-03-31 was $0.00.
- PHARMACYCLICS INC excess tax benefit from share-based compensation, operating activities for the quarter ending 2013-12-31 was $19.52M.
- PHARMACYCLICS INC excess tax benefit from share-based compensation, operating activities for fiscal 2014 was $34.88M, a 16.13% increase from fiscal 2013.
- PHARMACYCLICS INC excess tax benefit from share-based compensation, operating activities for fiscal 2013 was $30.03M.
- PHARMACYCLICS INC excess tax benefit from share-based compensation, operating activities for fiscal 2012 was $0.00.
- PHARMACYCLICS INC excess tax benefit from share-based compensation, operating activities for fiscal 2011 was $0.00.
| Period end | Excess Tax Benefit from Share-based Compensation, Operating Activities 3 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 6 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 9 month | Excess Tax Benefit from Share-based Compensation, Operating Activities 12 month |
|---|---|---|---|---|
| 2015-03-31 | $18.02M 10-Q · filed 2015-05-04 | $45.32M derived: sum of 2 quarters · filed 2015-05-04 | ||
| 2014-12-31 | $27.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $34.88M 10-K · filed 2015-02-18 | ||
| 2014-09-30 | $7.58M 10-Q · filed 2014-11-07 | |||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-04 | $19.52M derived: sum of 2 quarters · filed 2015-05-04 | ||
| 2013-12-31 | $19.52M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $30.03M 10-K · filed 2015-02-18 | ||
| 2013-09-30 | $10.51M 10-Q · filed 2014-11-07 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-02-18 | |||
| 2012-09-30 | $0.00 10-Q · filed 2013-11-07 | |||
| 2012-06-30 | $0.00 10-K · filed 2015-02-18 | |||
| 2011-06-30 | $0.00 10-K · filed 2014-02-26 |